Methotrimeprazine (Methoprazine, Nozinan) shortage status
No current shortage
Source: Health Canada shortage reports · Updated Jul 23, 2026
Methotrimeprazine has no current shortage reported in Canada. It has been in shortage before; the history is below.
A phenothiazine used to treat severe pain, agitation, and psychosis, often in palliative care.
Products affected
0 / 4
Reports on file
14
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
METHOPRAZINE
5MG · TABLET · AA PHARMA INC
DIN 02238404 · ended Jul 21, 2026 · Disruption of the manufacture of the drug.
Resolved
METHOPRAZINE
5MG · TABLET · AA PHARMA INC
DIN 02238404 · ended Mar 11, 2025 · Disruption of the manufacture of the drug.
Resolved
METHOPRAZINE
25MG · TABLET · AA PHARMA INC
DIN 02238405 · ended Dec 18, 2024 · Disruption of the manufacture of the drug.
Resolved
NOZINAN
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended Sep 29, 2023 · The product will continue to be on allocation.
Resolved
NOZINAN INJ 25MG/ML
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended May 13, 2022
Resolved
METHOPRAZINE
5MG · TABLET · AA PHARMA INC
DIN 02238404 · ended Mar 15, 2023 · Disruption of the manufacture of the drug.
Resolved
METHOPRAZINE
2MG · TABLET · AA PHARMA INC
DIN 02238403 · ended Mar 15, 2023 · Disruption of the manufacture of the drug.
Resolved
NOZINAN INJ 25MG/ML
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended Dec 15, 2022
Resolved
METHOPRAZINE
25MG · TABLET · AA PHARMA INC
DIN 02238405 · ended Aug 31, 2021 · Disruption of the manufacture of the drug.
Avoided
NOZINAN INJ 25MG/ML
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended Aug 7, 2020
Resolved
NOZINAN INJ 25MG/ML
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended May 4, 2020
Resolved
NOZINAN INJ 25MG/ML
25MG · SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 01927698 · ended Feb 20, 2019
Showing 12 of 14 reports. All reports are on file with Health Canada.
What's happening
There are no active shortage reports for Methotrimeprazine. Health Canada has 14 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.
Methotrimeprazine is classified under “ANTIPSYCHOTICS” (ATC N05AA).
Recent changes
Jul 23, 2026
Shortage resolved
Jul 16, 2026
Estimated end date pushed back : Jul 17, 2026 → Jul 24, 2026
Common questions
What is Methotrimeprazine used for?
A phenothiazine used to treat severe pain, agitation, and psychosis, often in palliative care.
When will Methotrimeprazine be back in stock in Canada?
Methotrimeprazine has no active shortage; supply is normal per Health Canada reports.
Why is Methotrimeprazine in shortage?
It isn't currently. Past reports and their reasons are listed above.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.